BRLF1 Polyclonal Antibody, APC-Cy5.5 Conjugated
Product Specifications
Background
Immediate-early transcription factor that controls the initiation of viral lytic gene expression and lytic reactivation from latency. Triggers lytic replication, and initiates a cellular senescence program in epithelial cells. Upregulates human DCR3/TNFRSF6B by directly binding to its receptor.
Synonyms
Replication and transcription activator; Rta; Immediate-early protein Rta; BRLF1
Gene ID
3783727
Swiss Prot
P03209
Host
Rabbit
Cross Reactivity
Human, Virus
Immunogen
81-180/605
Target
BRLF1
Clonality
Polyclonal
Isotype
IgG
Conjugation
APC-Cy5.5
Source
KLH conjugated synthetic peptide derived from Epstein-Barr virus Replication and transcription activator
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
650nm/694nm
Concentration
1µg/µl
Dilution
WB (WB=1:500-2000), IF (IF=1:100-500)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
3783727
Cross Reactivity Details
HHV4tp2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042175-100 1x 100 µL
Cytokeratin 8 (KRT8) (rB22.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details